Advertisement

A cross-sectional study on sarcopenia using EWGSOP1 and EWGSOP2 criteria with regional thresholds and different adjustments in a specific geriatric outpatient clinic

  • Sumru SavasEmail author
  • Emin Taşkıran
  • Fulden Z Sarac
  • Fehmi Akcicek
Research Paper

Key summary points

Aim

To evaluate the impact of (1) different adjustments of body size, (2) regional grip strength thresholds, and (3) EWGSOP1 and EWGSOP2 algorithm on sarcopenia prevalence using regional muscle mass thresholds in a geriatric outpatient clinic specific to endocrinological problems.

Findings

There was no sarcopenic patient with the height square adjusted regional muscle mass thresholds for EWGSOP1 and EWGSOP2. Sarcopenia prevalence was 11.7% with EWGSOP2, and 41.1% by the use of regional grip strength thresholds for EWGSOP2 with body mass index adjustments.

Message

The prevalence of sarcopenia varied significantly regarding the adjustment method for muscle mass in this specific patient group including normal to overweight and obese individuals, and also the regional grip strength thresholds whereas the comparison of the two criteria was not possible due to lack of sarcopenic individuals with height square adjusted regional muscle mass thresholds.

Abstract

Purpose

The aim of this study was to determine the prevalence of sarcopenia according to different methods in older outpatients using regional threshold values of muscle mass and muscle strength.

Methods

We used data from our university hospital’s geriatric outpatient clinic specific to endocrinological problems, retrospectively. Sarcopenia was defined according to European Working Group on Sarcopenia in Older People (EWGSOP)1 and EWGSOP2 criteria using regional threshold values of skeletal muscle mass (SMM) with the use of different adjustments, and also according to EWGSOP2 with regional threshold values of grip strength.

Results

Among 248 study participants, 53.6% were obese. There was no sarcopenic patient with the height square adjusted regional SMM thresholds for EWGSOP1 and EWGSOP2. Sarcopenia prevalence was 11.7% with EWGSOP2, and 41.1% by the use of regional grip strength thresholds for EWGSOP2 with body mass index adjustments for SMM. The comparison of EWGSOP1 versus EWGSOP2 was not possible due to lack of sarcopenic patients with height adjustment.

Conclusions

The prevalence of sarcopenia varied significantly with the application of different adjustment methods for SMM, and the use of regional grip strength thresholds in the specific patient group with normal to overweight and obese individuals. The use of regional thresholds of grip strength increased the prevalence of EWGSOP2-defined sarcopenia. The impact of the adjustment methods, the characteristics of the study population, and the regional thresholds should be taken into consideration while evaluating the results of sarcopenia studies.

Keywords

Sarcopenia criteria Skeletal muscle mass adjustment Regional thresholds Aged 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in this study were in accordance with the ethical standards of the Institutional Review Board of Clinical Research Ethics Committee of Faculty of Medicine-Ege University and with the 1964 Helsinki declaration and its later amendments.

Informed consent

Informed consent was obtained from all individual participants included in the study

References

  1. 1.
    Beaudart C, Biver E, Reginster JY, Rizzoli R, Rolland Y, Bautmans I et al (2017) Validation of the SarQoL(R), a specific health-related quality of life questionnaire or sarcopenia. J Cachexia Sarcopenia Muscle 8:238–244.  https://doi.org/10.1002/jcsm.12149 CrossRefPubMedGoogle Scholar
  2. 2.
    Lardiés-Sánchez B, Sanz-Paris A, Boj-Carceller D, Cruz-Jentoft AJ (2016) Systematic review: prevalence of sarcopenia in ageing people using bioelectrical impedance analysis to assess muscle mass. Eur Geriatr Med 7(3):256–261.  https://doi.org/10.1016/j.eurger.2016.01.014 CrossRefGoogle Scholar
  3. 3.
    Steffl M, Sima J, Shiells K, Holmerova I (2017) The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE). Clin Interv Aging 12:2003–2007.  https://doi.org/10.2147/CIA.S150826 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31CrossRefGoogle Scholar
  5. 5.
    Rosenberg IH (1989) Summary comments: epidemiologic and methodologic problems in determining nutritional status of older persons. Am J Clin Nutr 50:1231–1233CrossRefGoogle Scholar
  6. 6.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: european consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39(4):412–423.  https://doi.org/10.1093/ageing/afq034 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop et al (2011) Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12:403–409.  https://doi.org/10.1016/j.jamda.2011.04.014 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12(4):249–256.  https://doi.org/10.1016/j.jamda.2011.01.003 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med 69:547–558.  https://doi.org/10.1093/gerona/glu010 CrossRefGoogle Scholar
  10. 10.
    Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS et al (2014) Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc 15:95–101.  https://doi.org/10.1016/j.jamda.2013.11.025 CrossRefGoogle Scholar
  11. 11.
    Bahat G, Tufan A, Tufan F, Kilic C, Akpinar TS, Kose M et al (2016) Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 35(6):1557–1563.  https://doi.org/10.1016/j.clnu.2016.02.002 CrossRefPubMedGoogle Scholar
  12. 12.
    Bahat G, Tufan A, Kilic C, Aydın T, Akpinar TS, Kose M et al (2018) Cut-off points for height, weight and body mass index adjusted bioimpedance analysis measurements of muscle mass with use of different threshold definitions. Aging Male.  https://doi.org/10.1080/13685538.2018.1499081 (Epub ahead of print) CrossRefPubMedGoogle Scholar
  13. 13.
    Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S et al (1999) The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15(2):116–122.  https://doi.org/10.1016/S0899-9007(98)00171-3 CrossRefPubMedGoogle Scholar
  14. 14.
    Kondrup J, Allison SP, Elia M, Vellas B, Plauth M (2003) ESPEN guidelines for nutrition screening. Clin Nutr 22(4):415–421.  https://doi.org/10.1016/S0261-5614(03)00098-0 CrossRefPubMedGoogle Scholar
  15. 15.
    Katz S, Downs TD, Cash HR, Grotz RC (1970) Progress in development of the index of ADL. Gerontologist 10(1):20–30CrossRefGoogle Scholar
  16. 16.
    Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3):179–186CrossRefGoogle Scholar
  17. 17.
    Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198.  https://doi.org/10.1016/0022-3956(75)90026-6 CrossRefPubMedGoogle Scholar
  18. 18.
    Deurenberg P, Pietrobelli A, Wang ZM, Heymsfield SB (2004) Prediction of total body skeletal muscle mass from fat-free mass or intra-cellular water. Int J Body Compos Res 2:107–113Google Scholar
  19. 19.
    Podsiadlo D, Richardson S (1991) The timed ‘Up & Go’: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142–148CrossRefGoogle Scholar
  20. 20.
    Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A et al (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95(5):1851–1860.  https://doi.org/10.1152/japplphysiol.00246.2003 CrossRefGoogle Scholar
  21. 21.
    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Cardiovascular Health Study Collaborative Research Group et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–156CrossRefGoogle Scholar
  22. 22.
    Bischoff HA, Stahelin HB, MonschAU Iversen MD, Weyh A, von Dechend M et al (2003) Identifying a cut-off point for normal mobility: a comparison of the timed ‘up and go’ test in community-dwelling and institutionalised elderly women. Age Ageing 32(3):315–320CrossRefGoogle Scholar
  23. 23.
    Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM et al (2014) Grip strength across the life course: normative data from twelve British studies. PLoS One 9(12):e113637CrossRefGoogle Scholar
  24. 24.
    Ural D, Kılıçkap M, Göksülük H, Karaaslan D, Kayıkçıoğlu M, Özer N et al (2018) Data on prevalence of obesity and waist circumference in Turkey: systematic review, meta-analysis and meta regression of epidemiological studies on cardiovascular risk factors. Turk Kardiyol Dern Ars 46(7):577–590.  https://doi.org/10.5543/tkda.2018.62200 CrossRefPubMedGoogle Scholar
  25. 25.
    Kilavuz A, Meseri R, Savas S, Simsek H, Sahin S, Bicakli DH et al (2018) Association of sarcopenia with depressive symptoms and functional status among ambulatory community-dwelling elderly. Arch Gerontol Geriatr 76:196–201.  https://doi.org/10.1016/j.archger.2018.03.003 CrossRefPubMedGoogle Scholar
  26. 26.
    Bahat G, Tufan A, Kilic C, Öztürk S, Akpinar TS, Kose M et al (2019) Cut-off points for weight and body mass index adjusted bioimpedance analysis measurements of muscle mass. Aging Clin Exp Res 31(7):935–942.  https://doi.org/10.1007/s40520-018-1042-6 CrossRefPubMedGoogle Scholar
  27. 27.
    Schaap LA, Fox B, Henwood T, Bruyère O, Reginster JY, Beaudart C et al (2016) Grip strength measurement: towards a standardized approach in sarcopenia research and practice. Eur Geriatr Med 7(3):247–255.  https://doi.org/10.1016/j.eurger.2015.11.012 CrossRefGoogle Scholar
  28. 28.
    Dodds RM, Syddall HE, Cooper R, Kuh D, Cooper C, Sayer AA (2016) Global variation in grip strength: a systematic review and meta-analysis of normative data. Age Ageing 45(2):209–216.  https://doi.org/10.1093/ageing/afv192 CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J et al (2018) International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging 22(10):1148–1161CrossRefGoogle Scholar
  30. 30.
    Kim H, Hirano H, Edahiro A, Ohara Y, Watanabe Y, Kojima N et al (2016) Sarcopenia: prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr Gerontol Int 16(Suppl 1):110–122CrossRefGoogle Scholar
  31. 31.
    Rodríguez-García WD, García-Castañeda L, Vaquero-Barbosa N, Mendoza-Núñez VM, Orea-Tejeda A, Perkisas S et al (2018) Prevalence of dynapenia and presarcopenia related to aging in adult community-dwelling Mexicans using two different cut-off points. Eur Geriatr Med 9(2):219–225.  https://doi.org/10.1007/s41999-018-0032-8 CrossRefGoogle Scholar
  32. 32.
    Öztürk ZA, Kul S, Türkbeyler İH, Sayıner ZA, Abiyev A (2018) Is increased neutrophil lymphocyte ratio remarking the inflammation in sarcopenia? Exp Gerontol 110:223–229.  https://doi.org/10.1016/j.exger.2018.06.013 CrossRefPubMedGoogle Scholar
  33. 33.
    Öztürk ZA, Türkbeyler İH, Abiyev A, Kul S, Edizer B, Yakaryılmaz FD et al (2018) Health-related quality of life and fall risk associated with age-related body composition changes; sarcopenia, obesity and sarcopenic obesity. Intern Med J 48(8):973–981.  https://doi.org/10.1111/imj.13935 CrossRefGoogle Scholar
  34. 34.
    Reiss J, Iglseder B, Alzner R, Mayr-Pirker B, Pirich C, Kässmann H et al (2019) Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients. Age Ageing.  https://doi.org/10.1093/ageing/afz035 (Epub ahead of print) CrossRefPubMedGoogle Scholar
  35. 35.
    Locquet M, Beaudart C, Petermans J, Reginster JY, Bruyère O (2019) EWGSOP2 versus EWGSOP1: impact on the prevalence of sarcopenia and its major health consequences. J Am Med Dir Assoc 20(3):384–385.  https://doi.org/10.1016/j.jamda.2018.11.027 CrossRefPubMedGoogle Scholar
  36. 36.
    Su Y, Hirayama K, Han TF, Izutsu M, Yuki M (2019) Sarcopenia prevalence and risk factors among Japanese Community dwelling older adults living in a snow-covered city according to EWGSOP2. J Clin Med 8(3):E291.  https://doi.org/10.3390/jcm8030291 CrossRefPubMedGoogle Scholar
  37. 37.
    Mesinovic J, McMillan LB, Shore-Lorenti C, De Courten B, Ebeling PR, Scott D (2019) Metabolic syndrome and its associations with components of sarcopenia in overweight and obese older adults. J Clin Med 8(2):E145.  https://doi.org/10.3390/jcm8020145 CrossRefPubMedGoogle Scholar
  38. 38.
    Otsuka R, Matsui Y, Tange C, Nishita Y, Tomida M, Ando F et al (2018) What is the best adjustment of appendicular lean mass for predicting mortality or disability among Japanese community dwellers? BMC Geriatr 18(1):8.  https://doi.org/10.1186/s12877-017-0699-6 CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Bahat G, Kilic C, Ilhan B, Karan MA, Cruz-Jentoft A (2019) Association of different bioimpedanciometry estimations of muscle mass with functional measures. Geriatr Gerontol Int 19(7):593–597.  https://doi.org/10.1111/ggi.13668 CrossRefPubMedGoogle Scholar
  40. 40.
    Bahat G, Kilic C, Topcu Y, Aydin K, Karan MA (2018) Fat percentage cutoff values to define obesity and prevalence of sarcopenic obesity in community-dwelling older adults in Turkey. Aging Male.  https://doi.org/10.1080/13685538.2018.1530208 (Epub ahead of print) CrossRefPubMedGoogle Scholar
  41. 41.
    Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB et al (2007) Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 55:769–774.  https://doi.org/10.1111/j.1532-5415.2007.01140.x CrossRefPubMedGoogle Scholar
  42. 42.
    Cawthon PM, Peters KW, Shardell MD, McLean RR, Dam TT, Kenny AM et al (2014) Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci 69:567–575.  https://doi.org/10.1093/gerona/glu023 CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Kittiskulnam P, Carrero JJ, Chertow GM, Kaysen GA, Delgado C, Johansen KL (2017) Sarcopenia among patients receiving hemodialysis: weighing the evidence. J Cachexia Sarcopenia Muscle 8:57–68.  https://doi.org/10.1002/jcsm.12130 CrossRefPubMedGoogle Scholar

Copyright information

© European Geriatric Medicine Society 2019

Authors and Affiliations

  1. 1.Section of Geriatrics, Department of Internal Medicine, School of MedicineEge UniversityIzmirTurkey

Personalised recommendations